- Home
- MITQ vs TTNP Comparison
MITQ vs TTNP Comparison
Compare MITQ & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MITQ
- TTNP
- Stock Information
- Founded
- MITQ N/A
- TTNP 1991
- Country
- MITQ United States
- TTNP United States
- Employees
- MITQ N/A
- TTNP 4
- Industry
- MITQ Telecommunications Equipment
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MITQ Telecommunications
- TTNP Health Care
- Exchange
- MITQ Nasdaq
- TTNP Nasdaq
- Market Cap
- MITQ 5.5M
- TTNP 5.9M
- IPO Year
- MITQ 2021
- TTNP 1996
- Fundamental
- Price
- MITQ $0.65
- TTNP $4.40
- Analyst Decision
- MITQ
- TTNP
- Analyst Count
- MITQ 0
- TTNP 0
- Target Price
- MITQ N/A
- TTNP N/A
- AVG Volume (30 Days)
- MITQ 9.7M
- TTNP 44.6K
- Earning Date
- MITQ 05-15-2025
- TTNP 08-14-2025
- Dividend Yield
- MITQ N/A
- TTNP N/A
- EPS Growth
- MITQ N/A
- TTNP N/A
- EPS
- MITQ N/A
- TTNP N/A
- Revenue
- MITQ $18,613,000.00
- TTNP N/A
- Revenue This Year
- MITQ N/A
- TTNP N/A
- Revenue Next Year
- MITQ N/A
- TTNP N/A
- P/E Ratio
- MITQ N/A
- TTNP N/A
- Revenue Growth
- MITQ N/A
- TTNP N/A
- 52 Week Low
- MITQ $0.50
- TTNP $3.03
- 52 Week High
- MITQ $1.55
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- MITQ 57.86
- TTNP 48.35
- Support Level
- MITQ $0.61
- TTNP $4.23
- Resistance Level
- MITQ $1.10
- TTNP $4.65
- Average True Range (ATR)
- MITQ 0.06
- TTNP 0.27
- MACD
- MITQ 0.01
- TTNP -0.03
- Stochastic Oscillator
- MITQ 29.49
- TTNP 30.67
About MITQ Moving iMage Technologies Inc.
Moving iMage Technologies Inc is engaged in providing designed equipment as well as other off the shelf cinema products needed for contemporary cinema requirements. It offers technical, design and consulting services such as custom engineering, systems design, integration and installation and digital technology, as well as software solutions for operations enhancement and theatre management.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.